Advertisement

Das Wachstum von soliden Ehrlich-Ascites-Tumoren bei Mäusen nach Immunisierung mit BCG

  • Günther Gillissen
  • Günter Nehring
Article

Zusammenfassung

Solide Ehrlich-Ascites-Tumoren entwickeln sich bei NMRI-Han. Mäusen (Nicht-Inzuchttiere) langsamer, wenn die Tiere 20 Tage vor der Tumortransplantation mit BCG immunisiert worden waren. Dieser Effekt ist nicht zu beobachten, wenn BCG nur 2 Tage vor der Tumorübertragung injiziert wurde.

The influence of BCG-Vaccination on growth of solid ehrlich-ascites-tumours

Summary

The growth of solid Ehrlich-Ascites-Tumours in randombred NMRI-Han. mice is inhibited when the animals are vaccinated with BCG 20 days before tumour transplantation. Such an inhibition is not observed, when vaccination is accomplished only 2 days before tumour grafting.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Aron, St. A., andB. W. Janicki: Influence of prior sensitization with Mycobacteria on antibody response to protein antigen in Freund's adjuvans. Proc. Soc. exp. Biol. Med.124, 518 (1967).PubMedGoogle Scholar
  2. 2.
    Boyle, W., andD. A. L. Davies: Antigens of the surface of mouse ascites tumour cells. I. Studies with rabbit anti-mouse cell sera. Immunology11, 353 (1966).PubMedGoogle Scholar
  3. 3.
    Cruse, J. M.: Early suppression with late acceleration of syngeneic tumour growth by Freund's adjuvant. Z. Immun.-Forsch.132, 196 (1967).Google Scholar
  4. 4.
    Dannenberg, A. M. jr.: Cellular hypersensitivity and cellular immunity in the pathogenesis of tuberculosis: Specificity, systemic and local nature and associated macrophages enzymes. Bact. Rev.32, 85 (1968).PubMedGoogle Scholar
  5. 5.
    Davies, D. A. L.: Mouse hystocompatibility isoantigens derived from normal and from tumour cells. Immunology11, 115 (1966).PubMedGoogle Scholar
  6. 6.
    Finger, H.: Die Bedeutung bakterieller Adjuvantien für die Ausbildung der anaphylaktischen Schockbereitschaft bei Maus und Ratte. Z. Hyg.151, 248 (1965).Google Scholar
  7. 7.
    —— Die Adjuvanswirkung von Mycobakterien. Klin. Wschr.44, 1105 (1966).PubMedGoogle Scholar
  8. 8.
    Fischel, E. E., E. A. Kabat, H. C. Staerk, andA. E. Bezer: The role of tubercle bacilli in adjuvant emulsion on antibody to egg albumin. J. Immunol.69, 611 (1952).PubMedGoogle Scholar
  9. 9.
    Freund, J.: The effect of paraffin oil and mycobacteria on antibody formation and sensitization. Ann. J. clin. Path.21, 645 (1951).Google Scholar
  10. 10.
    ——, andK. J. McDermott: Sensitization to horse serum by means of adjuvants. Proc. Soc. exp. Biol.49, 548 (1942).Google Scholar
  11. 11.
    Gillissen, G.: Der Einfluß einer BCG-Impfung auf die Transplantationsreaktion. Beitr. Klin. Tuberk.139, 1 (1969).Google Scholar
  12. 12.
    Haas, R., u.R. Thomssen: Über den Entwicklungsstand der in der Immunbiologie gebräuchlichen Adjuvantien. In: Ergebnisse der Mikrobiologie, Immunitätsforschung und experimentellen Therapie, Bd. 34, S. 27. Berlin-Göttingen-Heidelberg: Springer 1961.Google Scholar
  13. 13.
    Markowitz, A. S., andCh. F. Lange jr.: Streptococcal related glomerulonephritis. I. Isolation, immunochemistry and comperative chemistry of soluble fractions from type 12 nephritogenic streptococci and human glomeruli. J. Immunol.92, 565 (1964).PubMedGoogle Scholar
  14. 14.
    Mayer, K. D.: The pathogenicity of the Ehrlich ascites tumour. Brit. J. exp. Path.47, 537 (1966).PubMedGoogle Scholar
  15. 15.
    Rapaport, F. T., R. M. Chase, andA. C. Solowey: Transplantation antigen activity of bacterial cells in different animal species and intracellular localization. Ann. N.Y. Acad. Sci.129, 102 (1966).Google Scholar
  16. 16.
    Rowley, D., andC. R. Jenkin: Antigenic cross-reaction between host and parasite as a possible cause of pathogenicity. Nature193, 151 (1962).PubMedGoogle Scholar
  17. 17.
    White, R. G.: Role of adjuvants in the production of delayed hypersensitivity. Brit. med. Bull.23, 39 (1967).PubMedGoogle Scholar
  18. 18.
    —— Concepts relating to the mode of action of adjuvants. In: Immunological standardization. (Int. Symp. on Adjuvants of Immunity.) Symposia Series Nr. 6, 49 (1967). Basel-New York: Karger.Google Scholar
  19. 19.
    ——, andJ. M. Connolly: Studies on antibody production. IV. The role of wax fraction of Mycobacterium tuberculosis in adjuvant emulsions on the production of antibody to egg albumin. J. exp. Med.102, 83 (1955).PubMedGoogle Scholar
  20. 20.
    ——, andE. Lederer: Correlation of adjuvant activity and chemical structure of wax D fractions of mycobacteria. Immunology7, 158 (1964).Google Scholar
  21. 21.
    Zabriskie, J. B., E. H. Freimer, andB. Seegal: An immunological relationship between streptococcal membranes and human heart tissue. Fed. Proc.23, 343 (1964).Google Scholar

Copyright information

© Springer-Verlag 1969

Authors and Affiliations

  • Günther Gillissen
    • 1
  • Günter Nehring
    • 1
  1. 1.Abt. Med. Mikrobiologie der Med. Fakultät der Technischen Hochschule in AachenGermany

Personalised recommendations